Achieve Life Sciences
ACHV
32 hedge funds and large institutions have $15.2M invested in Achieve Life Sciences in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
10% more funds holding
Funds holding: 29 → 32 (+3)
2.74% less ownership
Funds ownership: 21.6% → 18.87% (-2.7%)
13% less capital invested
Capital invested by funds: $17.5M → $15.2M (-$2.35M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$302K |
| 2 |
Franklin Resources
San Mateo,
California
|
+$267K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$227K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$199K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$157K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$916K |
| 2 |
Renaissance Technologies
New York
|
-$426K |
| 3 |
Walleye Capital
New York
|
-$245K |
| 4 |
Morgan Stanley
New York
|
-$222K |
| 5 |
Two Sigma Investments
New York
|
-$203K |
ACHV Hedge Fund Activity: Q3 2021 in Review
32 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q3 2021, worth a combined $15.2M — down 13% from $17.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ACHV positions and 4 closed out — a net gain of 4 holders — while 11 added to existing stakes and 9 trimmed.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $302K. The largest seller was Millennium Management, exiting entirely with an estimated $916K sold.
- 32 institutional investors held Achieve Life Sciences (ACHV) as of Q3 2021, up from 29 in Q2 2021.
- Funds reported $15.2M of Achieve Life Sciences stock for Q3 2021, down 13% quarter-over-quarter.
- 8 funds opened new Achieve Life Sciences positions in Q3 2021 and 4 closed out, a net change of +4 holders.
- The largest Achieve Life Sciences buyer in Q3 2021 was GSA Capital Partners, an estimated $302K added.
- The largest Achieve Life Sciences seller in Q3 2021 was Millennium Management, an estimated $916K sold.
Based on aggregated 13F filings for Q3 2021.